General-purpose models struggle with messy, industry-specific data. A three-layer AI stack from Trunk Tools cut document ...
Novartis already received FDA approval of ITVISMA as a gene therapy for the treatment of patients with SMA. Read why NVS ...
As more taxpayers turn to ChatGPT, Claude and other AI tools to file their ITRs, experts say the technology can simplify tax ...
Confessions II arrives amid a welter of promotional spectacle and global corporate partnerships. At heart, though, it’s Madonna retreating from projects stuck in development hell, and working through ...
With the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists, many may find themselves turning to generic ...
Angel Studios sucks the good will out of yet another semi-competent production with their last-minute, sketchy panhandling.
For most small business owners at the growth stage, a CFO is either absent or unaffordable. The financial clarity, cash-flow visibility, and management discipline that a CFO brings to a larger ...
When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...
The feather in the cap is “Minions & Monsters,” the third movie starring the Minions and easily the best, a shockingly delightful madcap comedy that feels like it could convert even the most staunch ...
China's Hybio Pharmaceutical said the U.S. Food and Drug Administration has accepted for reviews its abbreviated new ...
The U.S. Food and Drug Administration has agreed to review Swiss generics drugmaker Sandoz's two generic tirzepatide GLP-1s ...
Sandoz said the U.S. Food and Drug Administration accepted for review two applications for generic versions of Eli Lilly's Zepbound and Mounjaro, its popular shots for obesity and diabetes. The Swiss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results